BALA CYNWYD, Pa., June 24, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Sharecare, Inc. (Nasdaq - SHCR)

Under the terms of the agreement, Sharecare will be acquired by Altaris, LLC. for $1.43 per share in cash at closing. The investigation concerns whether Sharecare Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Altaris is paying fair value to shareholders of the Company. For example, the deal consideration is below the 52-week high of $1.80 for the Company’s shares.

Additional information can be found at https://www.brodskysmith.com/cases/sharecare-inc-nasdaq-shcr/.

PlayAGS, Incorporated (NYSE - AGS)

Under the terms of the agreement, AGS will be acquired by affiliates of Brightstar Capital Partners (“Brightstar”) for $12.50 per share in cash. The investigation concerns whether the AGS Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/playags-incorporated-nyse-ags/.

RBAZ Bancorp, Inc. (OTCPK - RBAZ)

Under the terms of the agreement, RBAZ will be acquired by Pima Federal Credit Union (“Pima”). Pima will purchase substantially all of the assets and assume substantially all of the liabilities of Republic Bank in an all-cash transaction where RBAZ shareholders will receive $22.00 in cash for each share of stock they hold. The investigation concerns whether the RBAZ Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/rbaz-bancorp-inc-otcpk-rbaz/.

Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)

Under the terms of the agreement, Deciphera will be acquired by ONO Pharmaceutical Co., Ltd. (“ONO”). ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash, for a total equity value of $2.4 billion. The investigation concerns whether the Deciphera Group Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether ONO is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/deciphera-pharmaceuticals-inc-nasdaq-dcph/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.